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ABSTRACT Understanding the effects of thin and thick ﬁlament proteins on the kinetics of Ca21 exchange with cardiac
troponin C is essential to elucidating the Ca21-dependent mechanisms controlling cardiac muscle contraction and relaxation. Unlike
labeling of the endogenous Cys-84, labeling of cardiac troponin C at a novel engineered Cys-53 with 2-(49-iodoacetamidoanilo)-
napthalene-6-sulfonic acid allowed us to accurately measure the rate of calcium dissociation from the regulatory domain of
troponin C upon incorporation into the troponin complex. Neither tropomyosin nor actin alone affected the Ca21 binding properties
of the troponin complex. However, addition of actin-tropomyosin to the troponin complex decreased the Ca21 sensitivity (;7.4-fold)
and accelerated the rate of Ca21 dissociation from the regulatory domain of troponin C (;2.5-fold). Subsequent addition of
myosin S1 to the reconstituted thin ﬁlaments (actin-tropomyosin-troponin) increased the Ca21 sensitivity (;6.2-fold) and
decreased the rate of Ca21 dissociation from the regulatory domain of troponin C (;8.1-fold), which was completely reversed by
ATP. Consistent with physiological data, replacement of cardiac troponin I with slow skeletal troponin I led to higher Ca21
sensitivities and slower Ca21 dissociation rates from troponin C in all the systems studied. Thus, both thin and thick ﬁlament
proteins inﬂuence the ability of cardiac troponin C to sense and respond to Ca21. These results imply that both cross-bridge
kinetics and Ca21 dissociation from troponin C work together to modulate the rate of cardiac muscle relaxation.
INTRODUCTION
Cardiac muscle utilizes troponin C (cTnC), an EF-hand Ca21
binding protein, to sense and translate the myoplasmic Ca21
signal into the cascade of events that ultimately leads to force
production and/or shortening (for review see Kobayashi and
Solaro (1)). In the muscle, cTnC is a subunit of the troponin
(cTn) complex, consisting also of cTnI (inhibitory subunit)
and cTnT (tropomyosin (cTm) binding subunit). The cTn
complex is anchored to the thin ﬁlament through multiple
protein interactions with actin and cTm. It is the dynamic,
Ca21-dependent interplay between these thin ﬁlament pro-
teins that permits myosin to strongly bind to actin and pro-
duce force.
It is generally assumed that the thin ﬁlament system
equilibrates with Ca21 very rapidly (much faster than the
mechanical events of contraction and relaxation) and thus
must possess fast Ca21 association and dissociation rates (for
review Gordon et al. (2)). This deﬁnitely is the case for the
Ca21 binding properties of isolated cTnC (3). However, the
Ca21 sensitivity of the regulatory domain of cTnC is in-
creased at least an order of magnitude by the binding of cTnI
and cTnT (4,5). The increase in Ca21 sensitivity of cTnC is
primarily due to a slowing of the Ca21 dissociation rate from
cTnC as cTnI and then cTnT is added to cTnC (from.1000/s
to ;120/s then ;35/s, respectively, at 15C (6,7)). Thus,
both cTnI and cTnT inﬂuence the Ca21 binding properties of
cTn in solution, by decreasing the rate of Ca21 dissociation
from cTnC. Furthermore, in the heart the cTn complex does
not function in isolation but as part of the thin ﬁlament
system.
It is unclear if cTm or actin6myosin can further affect the
kinetics of Ca21 dissociation from cTnC. There are
conﬂicting reports on the effects of cTm and actin-cTm on
the steady-state Ca21 binding properties of cTnC (8,9). The
most common approach to follow Ca21 binding to cTnC has
been to label one or both endogenous Cys residues with a
ﬂuorescent probe. Part of the confusion in the literature may
arise from the fact that ﬂuorescent labeling of the endoge-
nous Cys residues in cTnC alters the biochemical properties
of cTn (8,10,11). Thus, to adequately address these ques-
tions, a more accurate reporter of Ca21 binding and disso-
ciation from cTn must be developed.
Consistent with the strong inﬂuence of cTnI on the Ca21
binding properties of cTnC, developmental, transgenic, viral
mediated, and possibly disease related incorporation of slow
skeletal TnI (ssTnI) into cardiac muscle substantially affects
cardiac muscle performance (12–22). For instance, in the
presence of ssTnI, cardiac muscle force is: 1), more sensitive
to Ca21; 2), less sensitive to b-adrenergic stimulation; 3), more
resistant to pH changes; and 4), slower to relax. These
physiological phenomena can occur in the presence of cTnC
and cTnT, and can be attributed almost entirely to the in-
corporation of ssTnI into the myoﬁlaments. The biochemical
mechanisms behind the Ca21 sensitizing effects of ssTnI
have not been previously investigated.
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In this article we report the design of a cTnC, ﬂuorescently
labeled at a novel position, that minimally affects the bio-
logical activity or the Ca21 binding properties of cTnC in
isolated cTn and ssTn. The ﬂuorescent cTnC also reports the
Ca21 binding properties of the Tn complexes incorporated
into a more physiologically relevant biochemical system,
reconstituted thin ﬁlaments, in the absence and presence of
myosin S1.
The objective of these studies was to systematically
determine the effects of ssTnI, cTm, actin, and myosin S1 on
Ca21 binding and dissociation from the regulatory domain of
cTnC in the Tn complex. The ultimate goal of these studies is
to be able to better relate the biochemical behavior of cTnC
to its physiological function.
MATERIALS AND METHODS
Materials
Phenyl-sepharose CL-4B, Bradford reagent, Tween-20, and EGTA were
purchased from Sigma Chemical (St. Louis, MO). Quin-2 was purchased
from Calbiochem (La Jolla, CA). 2-(49-Iodoacetamidoanilo)napthalene-6-
sulfonic acid (IAANS) and phalloidin were purchased from Invitrogen
(Carlsbad, CA). Afﬁ-Gel 15 afﬁnity media was purchased from Bio-Rad
(Hercules, CA).
Protein isolation/puriﬁcation and mutagenesis
Recombinant human cTnC, cTnI, and cTnT3 (the most abundant cTnT
isoform in adult cardiac muscle (23)); recombinant rat ssTnI; rabbit fast
skeletal actin and myosin S1; and bovine cTm were isolated, puriﬁed, and
quantiﬁed by standard laboratory procedures (7,8,24,25). The mutations
C35S, T53C, and C84S in cTnC (herein denoted cTnCT53C) were constructed
from the cTnC pET3a plasmid utilizing techniques previously described (7).
Fluorescent labeling of cTnCT53C
cTnCT53C was dialyzed against 50 mM Tris, 6 M urea, 90 mM KCl, 1 mM
EGTA, pH 7.5. Labeling was initiated by the addition of three- to ﬁvefold
molar excess IAANS to cTnCT53C. The labeling reaction was allowed to
proceed in the dark for 5–8 h with gentle rocking at 4C. The reaction was
stopped by addition of 2 mM DTT, and unreacted IAANS was removed by
exhaustive dialysis against 10 mM MOPS, 90 mM KCl, pH 7.0. cTnCT53C
was determined to be 886 7% (two different batches; all data are shown as a
mean 6 SE of the mean) labeled with IAANS (herein denoted cTnCT53CIAANS)
utilizing the Bradford assay and the extinction coefﬁcient for IAANS at
325nm of 24,900 M1cm1 (5).
Reconstitution of the Tn complexes
The Tn complexes were prepared following a modiﬁed protocol previously
described by Tobacman and Lee (26). Brieﬂy, the Tn subunits (TnC, TnI,
and TnT) were ﬁrst dialyzed separately against 10 mMMOPS (pH 7.0), 4.6
M urea, 1 mM DTT, and 0.01% NaN3. After dialysis, the subunits were
mixed at a molar ratio of 1:1.5:1.5 (TnC/TnI/TnT) and incubated at room
temperature for 20 min. The complexes were subsequently dialyzed in
sequential steps against 4 L of 10 mmMOPS (pH 7.0), 0.5 mM DTT, 3 mM
MgCl2, 0.01% NaN3, and 1), 2 M urea, 1 M KCl; 2), 1 M KCl; and 3), 0.15
M KCl (this ﬁnal buffer was repeated three times) at 4C. Excess TnI and
TnT that precipitated during dialysis were removed by centrifugation at
14,000 rpm for 20 min at 4C (27).
Reconstitution of thin ﬁlaments
Puriﬁed actin ﬁlaments, myosin S1, and cTm were exhaustively dialyzed
separately in 10 mMMOPS, 150 mM KCl, 3 mMMgCl2, 1 mM DTT at pH
7.0. After dialysis actin was mixed with an equal molar ratio of phalloidin to
stabilize the actin ﬁlaments. Control experiments determined that the
addition of phalloidin to actin only marginally decreased the rates of Ca21
dissociation from cTnT53CIAANS (cTnC
T53C
IAANS-cTnI-cTnT; #1.3-fold) under the
experimental conditions described below (data not shown). Actin-phalloidin
(4 mM) and cTm (0.57 mM) were mixed in 10 mM MOPS, 150 mM KCl, 3
mM MgCl2, 1 mM DTT at pH 7.0 and kept on ice for $20 min. Tn
complexes (0.5 mM) were subsequently added to the actin-cTm mixture and
kept on ice for an additional$15 min before use. Slightly substoichiometric
Tn (7:1:0.88 (actin/cTm/Tn)) was utilized in the experiments to avoid the
possibility of contaminating free Tn. Control experiments veriﬁed that the
Ca21 dissociation rates from the reconstituted thin ﬁlaments were not
affected by increasing the actin/Tn ratios (ranging from 7:1:0.88 to 7:1:0.26
actin/cTm/Tn). Because the rates at the different actin/Tn ratios were
indistinguishable, all the data were pooled and included in the average value
(see Table 1). To address the effects of myosin binding on the Ca21 binding
properties of Tn, myosin S1 (1.14 mM) was added and allowed to equilibrate
with the reconstituted thin ﬁlaments for $3 min. For all the data shown in
the ﬁgures, the stoichiometry for the reconstituted thin ﬁlaments was
7:1:0.88:2 (actin/cTm/Tn/Mysoin S1). Initial experiments were performed
utilizing bovine cardiac actin. However, due to contamination of cardiac
actin with endogenous cTn and cTm, only 0.3 mM cTnT53CIAANS could be added
to 4 mM of cardiac actin before unbound cTnT53CIAANS was observed via
stopped-ﬂow kinetics. This problem was not observed with rabbit fast
skeletal actin. Moreover, incorporation of cTnT53CIAANS into reconstituted thin
ﬁlaments containing cardiac or skeletal actin led to indistinguishable Ca21
sensitivities and dissociation rates (data not shown). Thus, skeletal actin was
utilized for the collection of data, because similar results were obtained and
near stoichiometric concentrations of proteins could be used. Nonetheless,
potential problems could also arise from using unmatched ﬁlament proteins
(human cTn subunits, rat ssTnI, bovine cTm, and rabbit skeletal myosin S1).
However, the biochemical results obtained in this work are consistent with
previously observed physiological outcomes (14,28).
Steady-state ﬂuorescence
All steady-state ﬂuorescence measurements were performed using a Perkin-
Elmer LS 55 spectroﬂuorimeter at 15C. IAANS ﬂuorescence was excited at
330 nm and monitored at 450 nm (both bandwidths set at 10 nm) as
microliter amounts of CaCl2 were added to 2 mL of each Tn complex (0.15
mM) in a titration buffer containing 200 mMMOPS (pH 7.0), 150 mM KCl,
3 mM MgCl2, 1 mM DTT, 0.02% Tween-20, and 2 mM EGTA with
constant stirring. Reconstituted thin ﬁlaments6myosin S1 were prepared as
described above, and diluted in half with an appropriate solution to achieve
the same titration buffer composition (excluding Tween-20). For the myosin
S1 experiments, the change in area under the emission spectra from 370 to
440 nm was utilized to plot the acquired data. The [Ca21]free was calculated
using the computer program EGCA02 developed by Robertson and Potter
(29). The Ca21 sensitivities of conformational changes were reported as a
dissociation constant Kd, representing a mean of three to ﬁve separate titra-
tions 6 SE. The data were ﬁt with a logistic sigmoid function (mathemati-
cally equivalent to the Hill equation), as previously described (3).
Determination of Ca21 dissociation kinetics (koff)
Ca21 dissociation rates were measured using an Applied Photophysics
(Leatherhead, UK) model SX.18 MV stopped-ﬂow instrument at 15C. The
Ca21 dissociation rates from the unlabeled Tn complexes were directly
measured using the ﬂuorescent Ca21 chelator Quin-2. Quin-2 (150 mM
before mixing) was excited using a 150-W xenon arc source at 330 nm with
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emission monitored through a 510-nm broad band-pass interference ﬁlter
(Oriel, Stratford, CT). As in the steady-state measurements, IAANS
ﬂuorescence was excited at 330 nm. IAANS emission for the labeled Tn
complexes was monitored through a 420–470 nm band-pass interference
ﬁlter (Oriel) or the 510-nm broad band-pass interference ﬁlter. IAANS
emission for the reconstituted thin ﬁlaments 6 myosin S1 was monitored
through the 510-nm broad band-pass interference ﬁlter, excluding myosin
S1 experiments with ssTnT53CIAANS in which the emission was monitored
through a 415–490 nm band-pass interference ﬁlter (Newport, Irvine, CA).
Each koff represents an average of at least ﬁve traces, ﬁt with a single
exponential and repeated $14 times. The buffer used for the stopped-ﬂow
experiments was 10 mM MOPS, 150 mM KCl, 3 mM MgCl2, 1 mM DTT,
pH 7.0. To obtain the data traces, 200 mM Ca21 was added to the Tn
complexes (0.3 mM), or to the reconstituted thin ﬁlaments6 S1 and rapidly
mixed with buffer containing 10 mM EGTA in the stopped-ﬂow apparatus.
Control experiments were also conducted, in which the reconstituted thin
ﬁlaments6myosin S1 with Ca21were rapidly mixed with buffer containing
Ca21, or reconstituted thin ﬁlaments6 myosin S1 in the presence of EGTA
were rapidly mixed with buffer containing EGTA. These control traces were
subtracted from the data traces to correct for scattering artifacts. The relative
amplitudes of the scattering artifacts to the measured signals were 6.9 6
0.6%, 16 6 1%, and 6 6 1% for the reconstituted thin ﬁlaments, in the pres-
ence of S1 and the subsequent addition of Mg-ATP, respectively (n $ 11).
Skinned cardiac trabecula experiments
Solutions for the trabecula force measurements were prepared as previously
described (30). All experiments were performed at 15C. Unbranched
trabecula were dissected from the right ventricle of male Lewis-Brown
Norway F1 rats and placed overnight at 4C in relaxing solution containing
1% Triton-X. All trabeculae were used within 48 h of harvest. A reticule on
the eyepiece of the dissecting microscope was used to measure the width and
depth of the trabecula to calculate the cross-sectional area of the muscle by
assuming an elliptical circumference. Aluminum T-clips were used to mount
the trabecula between the arms of a high-speed length controller (model
322C, Aurora Scientiﬁc, Ontario, Canada) and an isometric force transducer
(model 403A, Aurora Scientiﬁc) in relaxing solution. The resting sarcomere
length was adjusted to ;2.2 mm utilizing the ﬁrst-order diffraction pattern
from a HeNe laser. The trabecula was then activated in a pCa 4.0 solution
and rapidly slackened after isometric force reached a plateau. The position of
the high-speed length controller and the analog output of the force transducer
were monitored by LabView 7.0 software (National Instruments, Austin,
TX). The total force was measured between the plateau and baseline levels.
The same procedure was utilized to obtain the resting force level of the
trabecula in a pCa 9.0 solution. The active force generated by the trabecula
in various pCa solutions was calculated as the total force minus the resting
force. Average maximal active force per cross-sectional area before
extraction of endogenous TnC was calculated to be 43 6 7 kN/m2, in
which resting force accounted for 9 6 1% of the total force (n ¼ 21).
Endogenous cTnC was extracted by soaking the trabecula for 30 min in
an extraction solution containing 10 mMHEPES, 5 mMEDTA, and 0.5 mM
triﬂuoperazine dihydrochloride (TFP) at pH 7.0. The trabecula was then
washed extensively with a pCa 9.0 solution to remove residual TFP. The
average postextraction force was 2 6 1% (N ¼ 11) of the maximal
preextraction force. cTnC was reconstituted into the trabecula by soaking the
extracted trabecula for 30 min in a pCa 9.0 solution containing 16.7 mM
wild-type TnC or cTnCT53CIAANS. The reconstituted trabecula was then exposed
to a series of pCa solutions ranging from pCa 9.0 to pCa 4.0, to measure the
Ca21 sensitivity of force development. The maximally activated tension of
the trabecula was obtained at pCa 4.0 before the extraction. pCa 4.0
activations were performed at the beginning, middle, and end of each force
versus pCa experiment, averaged, and used to normalize the submaximal
activations. During the course of the force versus pCa experiments, the
rundown in force (% reduction in force of the last pCa 4.0 contraction versus
the initial pCa 4.0 contraction) was 3 6 1% (N ¼ 21). For each protein, the
force versus pCa experiment was repeated ﬁve to nine times.
RESULTS
Characterization of the biochemical and
physiological properties of cTnCIAANS
T53C
To study thin and thick ﬁlament effects on Ca21 binding and
kinetics with cTnC, we developed a novel ﬂuorescent cTnC,
cTnCT53CIAANS. Thr-53 was mutated to Cys for the following
reasons: 1), a Thr to Cys mutation is relatively conservative;
2), Cys can be selectively labeled with environmentally
sensitive ﬂuorophores, such as IAANS; 3), Thr-53, within
the BC subdomain (consisting of helices B and C), moves
away from the NAD subdomain (consisting of helices N, A,
and D) as the regulatory domain of cTnC binds Ca21 and
interacts with cTnI, potentially changing its environment for
spectroscopic analysis (Fig. 1, A and B); 4), Thr-53 does not
directly ligate Ca21 and is spatially separated from the Ca21
binding loop, thus upon mutation should not directly inter-
fere with Ca21 binding; 5), Thr-53 does not interact with the
residues within cTnC that contribute to the core of the
hydrophobic pocket utilized to bind cTnI and that have been
shown to modulate Ca21 sensitivity of cTnC (7); and 6), Thr-
53 itself does not interact with cTnI or cTnT (as can be
observed from the Ca21 saturated cTn structures (31)). Thus,
substitution of Thr-53 with Cys and subsequent labeling with
IAANS was expected to minimally affect cTnC function, and
report the structural changes that occur in the regulatory
domain of cTnC upon Ca21 binding and dissociation.
As predicted, Fig. 1 B (B1), shows that the ﬂuorescence
emission intensity of cTnT53CIAANS was sensitive to Ca
21
binding, and decreased ;43% upon Ca21 saturation at 450
nm. The Ca21-dependent decrease in ﬂuorescence intensity
TABLE 1 Ca21 binding properties of the TnT53C complexes in
the various systems
System Kd (nM) Hill coefﬁcient koff (/s)
cTnT53C NA NA 42.5 6 0.3
cTnT53CIAANS 649 6 20 0.90 6 0.02 41.9 6 0.4
cTnT53CIAANS1cTm 702 6 10 0.90 6 0.01 36 .0 6 0.8
cTnT53CIAANS1Thin filament 4810 6 300 1.65 6 0.04 105 6 1
cTnT53CIAANS1Thin filament
1myosin S1
777 6 30 0.81 6 0.02 13.0 6 0.1
cTnT53CIAANS1Thin filament
1myosin S11ATP
5040 6 400 1.65 6 0.08 110 6 1
ssTnT53C NA NA 7.8 6 0.1
ssTnT53CIAANS 248 6 20 0.94 6 0.03 8.4 6 0.1
ssTnT53CIAANS1cTm 186 6 10 0.89 6 0.01 7.8 6 0.1
ssTnT53CIAANS1Thin filament 3530 6 200 1.52 6 0.07 85 6 1
ssTnT53CIAANS1Thin filament
1myosin S1
120 6 10 0.95 6 0.02 9.6 6 0.1
ssTnT53CIAANS1Thin filament
1myosin S11ATP
2870 6 500 1.62 6 0.06 79 6 1
NA represents measurements that are not applicable to the system studied.
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FIGURE 1 cTnCT53CIAANS behaves biochemically and physiologically similar to wild-type and endogenous cTnC. Panel A shows a ribbon representation of
the regulatory domain of cTnC in the apo state (1SPY (53)) and in Ca21 saturated cTn (1J1E; TnI, and TnT have been omitted for clarity (31)) utilizing the
software Rasmol (54). The regulatory domain of cTnC contains ﬁve helices denoted as N, A, B, C, and D. As shown in panel A, helices B and C (BC
subdomain) move away from the N, A, and D helices (NAD subdomain) upon Ca21 and TnI binding. The D-helix is pointing out of the page, with the
NAD subdomain colored light gray, the BC subdomain colored dark gray, and the Ca21 binding loop indicated by an asterisk (*). Thr-53 is depicted in a
stick representation. Panel B shows the IAANS emission spectra of the apo state (solid line) and Ca21 saturated state (dashed line, pCa 3.0) for cTnCT53CIAANS
in the cTn complex (B1), in reconstituted thin ﬁlaments (B2), plus myosin S1 (B3), and plus ATP (B4). The emission ﬂuorescence of the spectra was
calculated relative to the peak ﬂuorescence of each respective apo state, which was considered 100%. Panel C shows the time course of Ca21 dissociation
from wild-type cTn directly followed by an increase in quin-2 ﬂuorescence. Panel C also shows the EGTA-induced time courses of Ca21 dissociation from
cTnT53CIAANS and cTn
C84S
IAANS reported by an increase in IAANS ﬂuorescence. Overlaid with the kinetic traces are the ﬁtted exponential curves to the data
(smooth curves, which may be difﬁcult to discern). Panel D shows the Ca21-dependent increase in force development in skinned rat trabeculae containing
endogenous cTnC (:), wild-type cTnC (n), and cTnCT53CIAANS(n).
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of cTnT53CIAANS was only marginally affected by addition of
cTm (data not shown). However, upon incorporation of
cTnT53CIAANS into reconstituted actin-cTm (thin ﬁlament), the
ﬂuorescence intensity of cTnT53CIAANS increased ;63% at 450
nm upon Ca21 saturation (Fig. 1 B (B2)). Thus, the Ca21-
induced change in the ﬂuorescence of free cTnT53CIAANS was
spectroscopically distinct from that of cTnT53CIAANS bound to the
thin ﬁlament. In the presence of myosin S1, Ca21 saturation
of the reconstituted thin ﬁlaments induced a red shift in the
maximal emission ﬂuorescence and ;35% decrease in the
area under the emission spectra between 370 and 440 nm
(Fig. 1 B (B3)). Addition of Mg-ATP reversed the effects of
rigor myosin S1, causing the reconstituted thin ﬁlament
system to appear as if there was no myosin S1 in the solution
(Fig. 1 B (B2 and B4)). Thus, the ﬂuorescence of cTnT53CIAANS
reports the Ca21-dependent structural changes that occur in
the regulatory domain of cTnC in the cTn complex, and in
reconstituted thin ﬁlaments in the absence and presence of
myosin S1.
To determine whether the ﬂuorescence of cTnT53CIAANS re-
ported the Ca21-dependent structural changes associated
with the regulatory domain of cTnC, stopped-ﬂow studies
were performed. Ca21 dissociated from the regulatory do-
main of wild-type human cTn at a rate of 36.5 6 0.4/s
utilizing the ﬂuorescent Ca21 chelator quin-2 (Fig. 1 C),
which was similar to what we have previously reported for
the regulatory domain of wild-type human cTn under slightly
different environmental conditions (6). As the [Ca21]free was
rapidly chelated by EGTA, subsequently causing Ca21 to
dissociate from cTnT53CIAANS, the IAANS ﬂuorescence increased
at a rate of 41.96 0.4/s (Fig. 1 C and Table 1). Over a longer
time (200 s) there was an additional ;14% increase in
ﬂuorescence associated with the C-terminal domain of
cTnCT53CIAANS that occurred at 0.04 6 0.01/s (data not shown).
Thus, the decrease in IAANS ﬂuorescence that occurs
as cTnT53CIAANS binds Ca
21 can be largely attributed to the
regulatory N-terminal domain of cTnC. Furthermore, it ap-
pears that the initial and major IAANS ﬂuorescence increase
occurs at the actual Ca21 dissociation rate from the regu-
latory domain of cTn. This was not the case for the rate of
IAANS ﬂuorescence increase that occurred with the endog-
enously labeled Cys-35 of cTnC84SIAANS (10 6 0.3/s; Fig. 1 C).
Thus, as predicted and unlike cTnC84SIAANS, it appears that the
ﬂuorescence of cTnT53CIAANS follows and minimally affects the
Ca21 binding properties of the regulatory domain of cTn.
Consistent with this idea, skinned trabeculae reconstituted
with cTnCT53CIAANS developed force with nearly identical Ca
21
sensitivity (pCa 5.68 6 0.03) and Hill coefﬁcient (4.7 6
0.5) values as wild-type cTnC (pCa 5.70 6 0.02 and 5.5 6
0.8 Hill coefﬁcient) and endogenous cTnC (pCa 5.706 0.02
and 6.5 6 0.5 Hill coefﬁcient; Fig. 1 D). Furthermore,
cTnCT53CIAANS was able to substantially recover force (796 4%)
to a similar extent as wild-type cTnC (79 6 7%). Thus,
cTnCT53CIAANS behaved biochemically and physiologically sim-
ilar to wild-type and endogenous cTnC, at 15C.
Effects of ssTnI on the emission spectra of
cTnCIAANS
T53C in systems of increasing complexity
We also wanted to test whether cTnCT53CIAANS could be utilized
to follow Ca21 binding and dissociation from ssTn. Similar
to cTnT53CIAANS, Fig. 2 A shows that the ﬂuorescence emission
intensity of ssTnT53CIAANS ( cTnC
T53C
IAANS-ssTnI-cTnT) was sensi-
tive to Ca21 binding, and decreased ;41% upon Ca21
saturation at 450 nm. The Ca21-dependent decrease in ﬂuo-
rescence intensity of ssTnT53CIAANS was also only margin-
ally affected by addition of cTm (data not shown). Again
similar to cTnT53CIAANS, Ca
21 saturation of ssTnT53CIAANS incorpo-
rated into reconstituted actin-cTm increased the ﬂuorescence
intensity ;39% at 450 nm (Fig. 2 B). In the presence of
myosin S1, Ca21 saturation of the reconstituted thin ﬁla-
ments induced a red shift in the maximal emission ﬂuores-
cence and decreased the area under the emission spectra
between 370 and 440 nm by ;25% (Fig. 2 C), which could
be reversed to the thin ﬁlament state by addition of Mg-ATP
(Fig. 2 D). Thus, the Ca21-dependent structural changes that
occur in the regulatory domain of ssTn can be followed by
the ﬂuorescence of cTnCT53CIAANS in the ssTn complex, and
in reconstituted thin ﬁlaments in the absence and presence of
myosin S1.
Ca21 binding properties and Ca21 dissociation
rates from the Tn complexes
Fig. 3 A shows the Ca21-dependent decreases in IAANS
ﬂuorescence of cTnT53CIAANS and ssTn
T53C
IAANS. Consistent with
physiological observations that ssTnI increases the Ca21
sensitivity of cardiac muscle force development (14), the
Ca21 sensitivity of ssTnT53CIAANS was;2.6-fold higher than that
of cTnT53CIAANS (comparison of Kd values shown in Table 1).
The apparent Hill coefﬁcients for both Tn complexes were
less than one, indicative of a negative cooperative Ca21 bind-
ing process (Table 1).
Consistent with ssTnT53CIAANS displaying a higher Ca
21
sensitivity than cTnT53CIAANS, the rate of Ca
21 dissociation from
ssTnT53CIAANS was approximately ﬁvefold slower than that
reported by cTnT53CIAANS (Fig. 3 B). Fig. 3 B also demonstrates
that the rate of structural change reported by IAANS for both
Tn complexes occurs at the actual rate of Ca21 dissociation
from the unlabeled Tn complexes. Thus, cTnCT53CIAANS is an
excellent probe to follow the Ca21 binding and kinetic prop-
erties of cardiac and slow skeletal Tn.
Ca21 binding properties and Ca21 dissociation
rates from the Tn complexes in the presence
of cTm, or actin 6 myosin S1 without cTm
Because the Tn complex does not function in muscle in
isolation but as an integral part of the thin ﬁlament, it is
essential to understand the effects of actin and other relevant
proteins on the behavior of cTn and ssTn. Fig. 4 A and
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Table 1 show that the addition of cTm to either cTnT53CIAANS
or ssTnT53CIAANS had only marginal effects on their Ca
21 sensi-
tivities and apparent cooperativities. Fig. 4, B and C, also
show that the addition of cTm had little effect on the rate of
structural change in the ﬂuorescent Tn complexes as Ca21
was rapidly chelated by EGTA (for comparison see Table 1).
Additionally, in the absence of cTm, neither actin alone nor
actin in the presence or absence of myosin S1 affected the
apparent rate of Ca21 dissociation from cTnT53CIAANS (Fig. 4 B)
or ssTnT53CIAANS (Fig. 4 C). Thus, at the molar ratios used,
neither cTm, actin, nor myosin S1 have nonspeciﬁc effects
on the Tn complexes.
Ca21 binding properties and Ca21 dissociation
rates from the Tn complexes in the presence
of cTm-actin
Although cTm or actin alone had little effect on the Ca21
binding properties of the Tn complexes, the combination of
the two proteins drastically affected the Tn complexes. Fig. 5
A shows the Ca21-dependent increase in cTnT53CIAANS and
ssTnT53CIAANS ﬂuorescence in reconstituted thin ﬁlaments. In-
corporation of cTnT53CIAANS into reconstituted thin ﬁlaments
caused an ;7.4-fold decrease in the Ca21 sensitivity and
;1.8-fold increase in the Hill coefﬁcient of cTnT53CIAANS (Table
1). Similarly, incorporation of ssTnT53CIAANS into the recon-
stituted thin ﬁlaments caused an ;14-fold decrease in the
Ca21 sensitivity and ;1.6-fold increase in the Hill coefﬁ-
cient of ssTnT53CIAANS (Table 1). Furthermore, thin ﬁlaments
reconstituted with ssTnT53CIAANS were ;1.4-fold more Ca
21
sensitive than those reconstituted with cTnT53CIAANS. Thus,
incorporation of the Tn complexes into the thin ﬁlaments
decreased the Ca21 sensitivity of cTnC, but led to a positive
cooperative Ca21 binding process.
Consistent with the lower Ca21 sensitivities of the Tn
complexes on the thin ﬁlaments, Fig. 5 B shows that com-
pared to the isolated Tn complexes, the rates of Ca21 dis-
sociation from cTnT53CIAANS and ssTn
T53C
IAANS reconstituted thin
ﬁlaments increased ;2.5-fold and ;10.1-fold, respectively
(Table 1). Furthermore, in the reconstituted thin ﬁlaments,
Ca21 dissociated from ssTnT53CIAANS only;1.2-fold more slowly
than from cTnT53CIAANS. Thus, actin-cTm attenuates the Ca
21
sensitizing effects of ssTnI on cTnC.
FIGURE 2 Effects of ssTnI on the IAANS emission spectra of cTnCT53CIAANS in systems of increasing complexity. Panels A–D show the IAANS emission
spectra of the apo state (solid line) and Ca21-saturated state (dashed line, pCa 3.0) for cTnCT53CIAANS in the ssTn complex (A), in reconstituted thin ﬁlaments (B),
plus myosin S1 (C), and plus ATP (D). The emission ﬂuorescence of the spectra was calculated relative to the peak ﬂuorescence of each respective apo state,
which was considered 100%.
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Effects of myosin S1 on the Ca21 binding
properties and Ca21 dissociation rates from the
Tn complexes in reconstituted thin ﬁlaments
It has long been known that strong cross-bridge binding
increases the apparent Ca21 sensitivity of cTnC in muscle
(28). Consistent with this effect, Fig. 6 A shows that addition
of myosin S1 to the reconstituted thin ﬁlaments increased the
Ca21 sensitivity of cTnT53CIAANS and ssTn
T53C
IAANS ;6.2-fold and
29-fold, respectively (Table 1). Similar to that of the isolated
Tn complexes, the apparent Hill coefﬁcients of the re-
constituted thin ﬁlaments bound with myosin S1 indicated
a negative cooperative Ca21 binding process (Table 1). The
effect of myosin S1 could be completely reversed by the
addition of Mg-ATP, causing the Ca21 sensitivity of the Tn
complexes to be similar to that of the reconstituted thin
ﬁlaments in the absence of myosin S1 (Fig. 6 A; Table 1).
Furthermore, dissociation of attached myosin S1 from actin
by addition of Mg-ATP increased the Hill coefﬁcients back
FIGURE 3 Ca21 sensitivities and dissociation rates from cTnT53CIAANS and
ssTnT53CIAANS. Panel A shows the Ca
21-dependent decrease in IAANS
ﬂuorescence of cTnT53CIAANS (n) and ssTn
T53C
IAANS (d). Panel B shows the time
courses of Ca21 dissociation from unlabeled cTnT53C and ssTnT53C directly
followed by an increase in quin-2 ﬂuorescence. Panel B also shows the
EGTA-induced time courses of Ca21 dissociation from cTnT53CIAANS and
ssTnT53CIAANS reported by an increase in IAANS ﬂuorescence.
FIGURE 4 Ca21 binding properties and Ca21 dissociation rates from the
Tn complexes in the presence of cTm, or actin 6 myosin S1 without cTm.
Panel A shows the Ca21-dependent decrease in IAANS ﬂuorescence of
cTnT53CIAANS (n) and ssTn
T53C
IAANS (d) in the presence of cTm. Panel B shows the
EGTA-induced time courses of Ca21 dissociation from cTnT53CIAANS (0.3 mM)
in the presence of cTm (0.9 mM) or actin (4 mM) 6 myosin S1 (0.57 mM)
reported by an increase in IAANS ﬂuorescence. Panel C shows the EGTA-
induced time courses of Ca21 dissociation from ssTnT53CIAANS (0.3 mM) in the
presence of cTm (0.9 mM) or actin (4 mM)6myosin S1 (0.57 mM) reported
by an increase in IAANS ﬂuorescence. Increasing the concentration of
cTnT53CIAANS or ssTn
T53C
IAANSto 0.5 mM did not alter the results (data not shown).
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to that of the thin ﬁlament alone, which again indicated
a positive cooperative Ca21 binding process (Table 1).
Additionally, in the presence of rigor myosin S1, ssTnT53CIAANS
displayed ;6.5-fold higher Ca21 sensitivity than cTnT53CIAANS.
However, the Ca21 sensitivity of ssTnT53CIAANS was only ;1.8-
fold higher than that of cTnT53CIAANS after addition of Mg-ATP
(Table 1).
Consistent with the increased Ca21 sensitivity of the Tn
complexes upon addition of myosin S1 to the reconstituted
thin ﬁlaments, the rates of Ca21 dissociation reported by a
change in IAANS ﬂuorescence decreased ;8.1-fold and
;8.9-fold for cTnT53CIAANS and ssTn
T53C
IAANS, respectively (Fig. 6
B and Table 1). Fig. 6 C shows that the decrease in the rate of
Ca21 dissociation from the Tn complexes caused by myosin
S1 binding could be completely reversed by the addition of
Mg-ATP (Table 1). The qualitative effects on the Ca21 sen-
sitivity and Ca21 dissociation rate from cTnC in the re-
constituted thin ﬁlaments by actin-cTm and myosin S1 were
similar to that observed for skeletal TnC in reconstituted thin
FIGURE 5 Ca21 sensitivities and dissociation rates from cTnT53CIAANS and
ssTnT53CIAANS reconstituted thin ﬁlaments. Panel A shows the Ca
21-dependent
increase in IAANS ﬂuorescence of cTnT53CIAANS (h) and ssTn
T53C
IAANS (s) recon-
stituted thin ﬁlaments. Panel B shows the EGTA-induced time courses of
Ca21 dissociation from cTnT53CIAANS and ssTn
T53C
IAANS reconstituted thin ﬁlaments
reported by a decrease in IAANS ﬂuorescence.
FIGURE 6 Effects of myosin S1 on the Ca21 sensitivities and dissoci-
ation rates from cTnT53CIAANS and ssTn
T53C
IAANS reconstituted thin ﬁlaments. Panel
A shows the Ca21-dependent decrease in IAANS ﬂuorescence of cTnT53CIAANS
(n) and ssTnT53CIAANS (d) reconstituted thin ﬁlaments in the presence of myosin
S1. Panel A also shows the Ca21-dependent increase in IAANS ﬂuorescence
of cTnT53CIAANS (h) and ssTn
T53C
IAANS (s) reconstituted thin ﬁlaments in the
presence of myosin S1 and ATP. Panel B shows the EGTA-induced time
courses of Ca21 dissociation from cTnT53CIAANS and ssTn
T53C
IAANS reconstituted
thin ﬁlaments in the presence of myosin S1 reported by changes in IAANS
ﬂuorescence. The EGTA-induced decrease in cTnT53CIAANS ﬂuorescence as
opposed to the increase in ssTnT53CIAANS ﬂuorescence is due to the different
emission ﬁlters used to capture the signals. Panel C shows the EGTA-
induced time courses of Ca21 dissociation from cTnT53CIAANS and ssTn
T53C
IAANS
reconstituted thin ﬁlaments in the presence of myosin S1 and ATP reported
by an increase in IAANS ﬂuorescence.
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ﬁlaments (32). In the presence of myosin S1 (without Mg-
ATP), the rate of Ca21 dissociation from the thin ﬁlaments
reconstituted with ssTnT53CIAANS was only ;1.4-fold slower
than from thin ﬁlaments containing cTnT53CIAANS (Fig. 6 B and
Table 1). Thus, myosin S1 binding to actin-cTm potentiates
the Ca21 sensitizing effects of ssTnI on cTnC without pro-
portionally slowing the rate of Ca21 dissociation.
DISCUSSION
To determine the effects of myoﬁlament proteins on cTnC
function, we have ﬂuorescently labeled cTnC at a novel
position. This was accomplished by mutating the endoge-
nous Cys residues to Ser and Thr-53 to Cys, which was then
labeled with the environmentally sensitive ﬂuorophore
IAANS, resulting in cTnCT53CIAANS. When incorporated into
the cTn complex, cTnCT53CIAANS biochemically and physiolog-
ically responded to changes in [Ca21] similarly to wild-type
and endogenous cTnC. This cannot be stated for the
functional behavior of cTnC labeled with IAANS on either
endogenous Cys-35 or 84. Labeling of the endogenous Cys
residues on cTnC has been shown to modify the Ca21
binding properties of cTn and the Ca21-dependent ATPase
activity of cardiac reconstituted thin ﬁlaments (Fig. 1 C and
(8,10,11)). Furthermore, the ability of cTnCT53CIAANS to remain
spectroscopically sensitive to Ca21 binding in the Tn com-
plex and on the thin ﬁlament is unique and different from that
observed with single labeling of either endogenous Cys
residue of cTnC (8,11). Thus, cTnCT53CIAANS is a very useful and
novel sensor to test the effects of thin and thick ﬁlament
proteins on the Ca21 binding properties of the cTn and ssTn
complexes.
Neither cTm nor actin (6 S1) affected the Ca21 binding
properties of the Tn complexes. However, reconstitution of
the thin ﬁlaments decreased the Ca21 sensitivity and in-
creased the rate of Ca21 dissociation from both Tn complexes.
Thus, actin-cTm drastically attenuated the Ca21 sensitizing
effects of cTnI and cTnT on cTnC. This observation is con-
sistent with cTnC and actin competing for binding to the
C-terminal domain of cTnI (for review see Kobayashi and
Solaro (1)). This competition for TnI binding may be the
reason for the reduced Ca21 sensitivity of the troponin com-
plexes upon incorporation into the reconstituted thin ﬁla-
ments.
The positive cooperativity of Ca21 binding observed in
the reconstituted thin ﬁlaments may arise from Ca21 binding
to one stoichiometric unit (seven actins, one cTm dimer, and
one cTn complex), allowing cTnC to out compete actin for
cTnI, resulting in cTm repositioning on actin. This cTm
movement is thought to span over a distance greater than a
single stoichiometric unit (for review see Solaro and Rarick
(33)) and may weaken the cTnI-actin interactions in
neighboring stoichiometric units. These weakened cTnI-
actin interactions will effectively increase the probability of
cTnC binding to cTnI, increasing the apparent Ca21
sensitivity of the neighboring cTnCs and thus cooperativity.
Consistent with this hypothesis, positive cooperativity of
Ca21 binding was not observed with the Tn complexes alone
or with ‘‘mini’’-thin ﬁlaments that contain only a single
stoichiometric unit (8,9,34).
If cTnC and actin truly act as competitive antagonists for
cTnI binding, and this was the sole mechanism determining
the Ca21 sensitivity of cTnC on the thin ﬁlament, then the
rate of Ca21 dissociation from cTnC bound to cTnI in the
different systems should not change. Alternatively or addi-
tionally, the Ca21 sensitivity, cooperativity, and dissociation
rate from the Tn complexes on the thin ﬁlaments may be
modulated by cTnT-cTm interactions or direct cTnT-cTnC
interactions (for review see Farah and Reinach (35)), which
may change depending on the state of the thin ﬁlament.
Consistent with cTnT and cTm inﬂuencing the Ca21 sen-
sitivity of cTn on the thin ﬁlament, isoform variations and
disease-related mutations in cTnT and cTm have been shown
to affect the Ca21 sensitivity and cooperativity of cardiac
muscle force development, even in the presence of ssTnI
(6,36,37).
The myosin S1 effects on the reconstituted thin ﬁlaments
were studied with two myosin S1 per stoichiometric unit.
This concentration of myosin S1 is at the upper limit for the
physiological range of myosin strongly bound to a stoichio-
metric unit during maximal contraction in muscle (for re-
view (2,38)). The effect of myosin S1 on the Ca21 sensitivity
of the reconstituted thin ﬁlaments is consistent with strong
binding cross-bridges increasing the Ca21 sensitivity of cTnC
in cardiac muscle (11,28,39,40). For cTn, the myosin S1
induced increase in the Ca21 sensitivity of the thin ﬁlaments
(approximately sixfold) could be explained by a proportion-
ally similar decrease in the rate of Ca21 dissociation from
cTnC (approximately eightfold). The effects of myosin S1
binding to the thin ﬁlaments could be completely reversed
by the addition of Mg-ATP. The molecular mechanism(s)
behind these S1 effects on the thin ﬁlament are unknown.
However, myosin binding to actin moves Tm further on actin
than does Ca21 binding alone (for review see Gordon et al.
(38)) and drastically increases the afﬁnity of cTm for actin
(41). Thus, myosin binding to actin may cause a structural
change in actin and move cTm to ultimately increase the
probability of cTnI-cTnC binding. Furthermore, the posi-
tive cooperativity of Ca21 binding to the thin ﬁlaments
was abolished in the presence of myosin S1. Because our
Ca21 binding studies were performed after the addition of
myosin S1, it is likely that the rigor binding of myosin
S1 already displaced cTm so that the binding of Ca21 to
the Tn complexes had no effect on repositioning cTm (the
proposed mechanism for the cooperativity). Consistent with
the effects of myosin S1 on the thin ﬁlaments, the addition
of NEM-S1 (an irreversible rigor like myosin S1) to cardiac
muscle increased the Ca21 sensitivity of force development
with a reduced cooperativity (for review see Moss et al.
(42)).
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It is generally assumed that Ca21 dissociation from cTnC
in muscle is very rapid and that the rate of cross-bridge
detachment is the primary determinant of cardiac muscle
relaxation (for review see Gordon et al. (2)). Our data clearly
demonstrate that myosin binding to actin drastically slows
the rate of Ca21 dissociation from cTn to a rate comparable
to that of cardiac muscle relaxation (;5–11/s at similar ionic
strength and the same temperature used in this article (15C);
(43–45)). The fact that myosin binding slows the Ca21
dissociation rate from cTnC incorporated into the thin
ﬁlament ﬁts well with recent mathematical models predicting
this phenomenon to describe steady-state (46) and kinetic
(47) muscle data. Assuming the reconstituted thin ﬁlament is
a reasonable model system for studying the kinetics of Ca21
dissociation from cTnC in muscle, then it may be that both
cross-bridge kinetics and Ca21 dissociation from cTn work
together to modulate the rate of cardiac muscle relaxation.
However, the reconstituted thin ﬁlaments represent only two
extreme conditions, unbound myosin and rigor bound
myosin. At the physiological salt conditions used in this
work it is not possible to address the effects of cycling cross-
bridges on cTnC.
Consistent with the fact that ssTnI increases the Ca21
sensitivity of force development and slows the rate of cardiac
muscle relaxation and relengthening (14–17,21), we have
demonstrated that biochemically ssTn displayed a higher
Ca21 sensitivity and slower Ca21 dissociation rate than cTn,
under all experimental conditions. These data further support
the hypothesis that the Ca21 dissociation rate from Tn may
inﬂuence the rate of cardiac muscle relaxation. Interestingly,
there are numerous cTnI mutations linked to hypertrophic
cardiomyopathy that also display increased myoﬁlament and
force Ca21 sensitivities (8,48,49). However, transgenic
expression of ssTnI in an adult heart does not trigger a hy-
pertrophic response and actually improves cardiac muscle
performance under various pathophysiological conditions
(14,50–52). It may be that the hypertrophic cardiomyopathy
related cTnI mutants increase the myoﬁlament Ca21 sensi-
tivity through different mechanism(s) from that of ssTnI. For
instance, unlike ssTnI, several hypertrophic cardiomyopathy
linked cTnI mutants did not directly increase the Ca21 sen-
sitivity of cTnC in the Tn complex (8).
Steady-state afﬁnities are set by the rates of association
and dissociation. It is clear from the data that the relative
changes in the Ca21 sensitivity of the Tn complexes that
occur upon incorporation into the reconstituted thin ﬁlaments
in the absence and presence of myosin S1 are not always
associated with proportional changes in the respective Ca21
dissociation rates. Contrary to dogma, these results imply
that the Ca21 association rates to cTn and ssTn in the various
biochemical systems must also change. This hypothesis is
consistent with the fact that several Ca21 sensitizing
mutations in cTnCF27W increased the Ca21 association rates
to the regulatory domain of isolated cTnC (7). As a
consequence of this phenomenon, ssTnI has a much larger
effect on the Ca21 sensitivity of the Tn complex incorporated
into the reconstituted thin ﬁlaments in the presence of
myosin S1 than on the rate of Ca21 dissociation, compared to
that of cTnI. This mechanism would allow cardiac muscle
expressing ssTnI to be substantially more sensitive to Ca21,
while only marginally affecting the rate of cardiac muscle
relaxation. Consistent with our results, cardiac muscle ex-
pressing ssTnI exhibits a much larger increase in the Ca21
sensitivity of force development than a decrease in the rate of
muscle relaxation or relengthening (14,17,21).
In summary we developed a novel ﬂuorescent cTnC that
accurately reports the rate of Ca21 dissociation from cTnC
incorporated into cTn and ssTn. Furthermore, the ﬂuorescent
cTnC also reports the Ca21 binding properties of the Tn
complexes reconstituted into thin ﬁlaments in the absence
and presence of myosin S1. This study demonstrated: 1),
reconstitution of cTnC into the thin ﬁlament dramatically
increases the Ca21 dissociation rate from cTn; 2), myosin S1
substantially decreases the rate of Ca21 dissociation from
cTn reconstituted into thin ﬁlaments to a rate similar to
reported rates of cardiac muscle relaxation; 3), ssTn
possesses a higher Ca21 sensitivity than cTn in all systems
studied; and 4), ssTn possesses a slower Ca21 dissociation
rate than cTn reconstituted into thin ﬁlaments in the absence
and presence of myosin S1. Thus, all the major thin ﬁlament
proteins (TnI, TnT, Tm, and actin) have direct or indirect
effects on the Ca21 sensitivity and dissociation rate from
cTnC. Even the thick ﬁlament protein myosin can drastically
alter the sensitivity and kinetics of Ca21 dissociation from
cTnC. All these proteins inﬂuence the ability of cTnC to sense
and respond to the Ca21 signal, allowing cardiac muscle to
be ﬁnely or grossly tuned to perform mechanically on a beat-
to-beat basis.
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